tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 108 are a BUY (87.1%), 16 are a HOLD (12.9%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 62.16% that have a potential upside of 57.55% achieved within 397 days. Previously, Scott Henry worked at ROTH MKM.
Scott Henry’s has documented 256 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Financial Services, Utilities, Industrials sectors.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2023
$119
$45 (60.81%)
$124
1 months 20 days ago
(10-Aug-2026)
7/12 (58.33%)
$43.24 (57.07%)
320
Hold Since 17-Jul-2026
$90
$16 (21.62%)
$91
1 months 20 days ago
(10-Aug-2026)
0/2 (0%)
$14.24 (18.80%)
Hold Since 03-Mar-2025
$90
$16 (21.62%)
$77
11 months 21 days ago
(09-Oct-2025)
9/9 (100%)
$-0.78 (-0.86%)
307
Buy Since 12-Mar-2025
$115
$41 (55.41%)
$85
1 years 6 days ago
(24-Sep-2025)
1/2 (50%)
$20.01 (21.07%)
153
Buy Since 10-Jul-2025
$121
$47 (63.51%)
1 years 13 days ago
(17-Sep-2025)
6/7 (85.71%)
$25.64 (26.89%)
454
What Year was the first public recommendation made by Scott Henry?
